SCHEMBL3349828

SCHEMBL3349828

Cc1cc(-c2ccccc2)cc(N2CCN(C)CC2)n1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 2/20 0.68
DRD2 P14416 1/20 0.68
HRH4 Q9H3N8 5/20 0.57
HTR3A P46098 4/20 0.57
HTR3E A5X5Y0 1/20 0.57
HTR3B O95264 1/20 0.57
HTR3D Q70Z44 1/20 0.57
HTR3C Q8WXA8 1/20 0.57
KMT2A Q03164 1/20 0.56
KDM4E B2RXH2 1/20 0.55
LMNA P02545 1/20 0.55
MAPT P10636 1/20 0.55
TSHR P16473 1/20 0.55
MAPK1 P28482 1/20 0.55
HSD17B10 Q99714 1/20 0.55
ADORA2A P29274 1/20 0.52
ADORA1 P30542 1/20 0.52
HRH2 P25021 1/20 0.50
HRH1 P35367 1/20 0.50
HRH3 Q9Y5N1 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3346394 0.85 DRD2 (0.64) HTR6DRD2HRH4HTR3AHTR3E
SCHEMBL13621969 0.83 HTR3A (0.58) HTR6HRH4HTR3AHTR3EHTR3B
SCHEMBL3352972 0.82 HTR6 (0.62) HTR6DRD2HRH4HTR3AHTR3E
SCHEMBL3345464 0.82 HTR6 (0.57) HTR6DRD2HRH4HTR3AHTR3E
Hydrochloric Acid SCHEMBL3347629 0.81 HTR6 (0.61) HTR6DRD2HRH4HTR3AHTR3E
SCHEMBL3347950 0.81 HTR6 (1.00) HTR6DRD2HRH4HTR3AHTR3E
SCHEMBL3347895 0.80 DRD2 (0.61) HTR6DRD2HRH4HTR3AHTR3E
SCHEMBL3346261 0.79 CYP1A2 (0.57) HTR6DRD2HTR3AHTR3EHTR3B
Fumaric Acid SCHEMBL3380344 0.78 HTR6 (0.53) HTR6DRD2HRH4HTR3AHTR3E
Fumaric Acid SCHEMBL3380345 0.78 HTR6 (0.53) HTR6DRD2HRH4HTR3AHTR3E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010053388-A1 NEW 4,6-DISUBSTITUTED 2-(4-METHYLPIPERAZIN-1-YL)PYRIDINE DERIVATIVES, A PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITION CONTAINING THESE COMPOUNDS, THEIR USE, A METHOD FOR MODULATING MONOAMINERGIC RECEPTOR ACTIVITY AND A MONOAMINERGIC RECEPTOR MODULATING AGENT INSTYTUT FARMAKOLOGII POLSKIEJ AKADEMII NAUK (PL) 2010-05-14 WO claimed
WO-2010053388-A1 NEW 4,6-DISUBSTITUTED 2-(4-METHYLPIPERAZIN-1-YL)PYRIDINE DERIVATIVES, A PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITION CONTAINING THESE COMPOUNDS, THEIR USE, A METHOD FOR MODULATING MONOAMINERGIC RECEPTOR ACTIVITY AND A MONOAMINERGIC RECEPTOR MODULATING AGENT INSTYTUT FARMAKOLOGII POLSKIEJ AKADEMII NAUK (PL) 2010-05-14 WO disclosed